Beta Lactam Antibiotics

Domestic Only

Generic Name	Strength	Dosage Form	Therapeutic Category
CEPHALOSPORINS
Cefotaxime sodium	(125mg), (250mg), (500mg), (1gm), (2gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Cefotaxime & Sulbactam	(1.5gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Cefazolin sodium	(250mg), (500mg), (1gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Cefoperazone sodium	(250mg), (500mg), (1gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Cefoperazone & Sulbactam	(1gm), (1.5gm), (2gm), (3gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Cefoperazone & Tazobactam	(1.125gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Ceftriaxone sodium	(125mg), (250mg), (500mg), (1gm), (2gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Ceftriaxone & Sulbactam	(187.5mg), (375mg), (750mg), (1gm), (1.5gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Ceftriaxone & Tazobactam	(125mg), (250mg), (281.25mg), (500mg), (562.5mg), (1gm), (1.125gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Cefepime Hydrocloride	(250mg), (500mg), (1gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Cefepime & Sulbactam	(1.5gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Cefepime & Tazobactam	(1.125gm), (2.25gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Cefuroxime sodium	(250mg), (750 mg), (1.5gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Cefuroxime & Sulbactam	(1.5gm), (2.25gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Cefpirome & Sulbactam	(1.5gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Ceftazidime	(250mg), (500mg), (1gm), (2gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Ceftazidime & Sulbactum	(1.5gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Ceftazidime & Tazobactam	(1.125gm), (2.25 gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Ceftazidime & Avibactam	(2.5gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Ceftizoxime	(1gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Ceftizoxime & Sulbactam	(1.5gm)	Dry Powder Injection	Beta-Lactam Antibiotic
CARBAPENEMS
Meropenem	(125mg), (250mg), (500mg), (1gm), (2gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Meropenem with EDTA	(1gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Meropenem & Sulbactam	(750mg), (1.5gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Meropenem & Sulbactam with EDTA	(1.5gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Meropenem & Tazobactum	(1.125gm), (1.5 gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Doripenem	(500mg)	Dry Powder Injection	Beta-Lactam Antibiotic
Imipenem & Cilastatin	(500mg), (1gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Ertapenem sodium	(500mg), (1gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Aztreonam	500mg, 1gm	Dry Powder Injection	Beta-Lactam Antibiotic
PENICILLINS
Ampicillin Sodium	(500mg), (1gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Ampicillin & Cloxacillin	(250mg), (500mg), (1gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Ampicillin & Sulbactam	(1.5gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Amoxycillin and Potassium Clavulanate	(150mg), (300mg), (600mg), (1.2 g)	Dry Powder Injection	Beta-Lactam Antibiotic
Benzyl Penicillin	(5 lakh IU)	Dry Powder Injection	Beta-Lactam Antibiotic
Benzathine Penicillin	24 lakh IU)	Dry Powder Injection	Beta-Lactam Antibiotic
Cloxacillin sodium	(250mg), (500mg), (1gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Flucloxacillin	(500mg), (1gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Piperacillin & Tazobactam	(1.125gm), (2.25gm), (4.5gm)	Dry Powder Injection	Beta-Lactam Antibiotic
Ticarcillin and Clavulanate	(3.1gm)	Dry Powder Injection	Beta-Lactam Antibiotic

*Domestic Only

Latest News on Your Doctor's Blog

Loading…

21December
2019

Our drug Ranitidine Tablets are safe: Taj Pharmaceuticals

Ranitidine is a commonly prescribed medicine for countering acidity and is on the WHO’s Model List of Essential Medicines. Our drug Ranitidine Tablets are safe: Taj Pharmaceuticals Amid a raging controversy over commonly used heartburn drug Ranitidine, Mumbai-based Taj Pharmaceuticals Limited today said that its formulation drug is safe. The company said that the test results found that Taj Pharmaceuticals’ Ranitidine tablets was within the “acceptable limits” for the presence of a probable cancer causing substance. On 29th September 2019 US FDA had raised a global alarm over the presence of a probable cancer causing substance—NDMA or N-Niteosodimethylamine—in some Ranitidine medicines. The company is likely to continue Ranitidine drug sale, following the report. “The Company intends to provide additional updates in the next coming days, including potential recommencement,” it said in a statement. Taj Pharma Ranitidine Free of ALL NDMA / NDEA Impurities NDMA Risk Assessment Report is done in much more advanced for all potential APIs (Valsartan) on our ROS of Ranitidine Hydrochloride and analyzed few batches for NDMA content in Ranitidine HCL API by validated LC-MS/MS and GC-MS methods. As per our initial investigation and assessment report, it is found that the formation of NDMA in ROS of our […]

posted by Taj Pharma

14March
2020

India COVID-19 coronavirus by city and state

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Coronavirus FAQs Coronavirus in India: how the 2019-nCoV could impact the world’s second–most populated country Coronavirus-affected countries: Italy Middle East South Korea Japan Singapore Malaysia China USA UK Thailand Philippines Latest on India coronavirus (Covid-19) situation, followed by details on states, union territories and cities. For latest coronavirus news updates, jump to NCR, Punjab, Tamil Nadu, Haryana, Telangana, Rajasthan, Uttar Pradesh, Karnataka, Bihar, Ladakh, Jammu and Kashmir, Andhra Pradesh, Maharashtra, Odisha, Himachal Pradesh, Mizoram, Kerala.

posted by Doctor

7July
2022

Top Generic Pharmaceutical Company

Each day is a brand-new opportunity for Taj Pharma Taj Pharmaceuticals has established itself as a top generic pharmaceutical company. With a product range that exceeds 4600 compositions across all therapeutic areas, it has successfully won the heart of consumers across the globe. The company is acclaimed as one of the top 10 pharmaceutical firms in India and the world’s leader in generics. Taj Pharma India is a market leader in therapeutic fields like Critaical care, transplantation, virology, and cancer. Taj Pharma’s generics and pharmaceuticals businesses work well together, and our knowledge of the bio-similar generic drugs enable us to create individualized therapeutic strategies and integrated healthcare solutions. The range of healthcare services and products offered by Taj Pharmaceutical includes genetic risk factor screening, disease diagnosis, disease prevention, treatment, and monitoring of the effectiveness of those treatments. Manufacturing of Lyophilized Products Taj Pharmaceuticals has spent the last ten years creating a brand-new category of healthcare organization. Building trust-based, long-lasting partnerships with Taj Pharma stakeholders is a goal shared by the whole Taj Pharma Group. This is clear in several ways. Through the discovery and development of cutting-edge, scientifically sound medications and services that enhance people’s health and general well-being worldwide, […]

posted by Taj Pharma

16January
2022

Taj Pharma introduces Covid-19 drug Molnupiravir in India

Pharmaceutical firm Taj Pharma has announced that it has introduced Covid-19 treatment drug Molnupiravir under brand name “Molnutaj” in India. Molnupiravir is for treatment of adult patients hospitalised with COVID-19, under certain conditions, drug maker said.

posted by Taj Pharma

16July
2021

Taj Pharma has 4000+ products approved by the FDA to manufacture

11October
2019

Biosimilars have the same clinical effect as a generic but are only as similar to the original branded drug as validation technologies can confirm. When a drug company introduces a costly new drug, they can do so because they have an exclusive patent on it. Once drug patents expire, pharmaceutical companies can copy that branded drug, and sell it for significantly less as a generic. The Hatch-Waxman Act of 1984 — designed to reduce the cost of patient therapies— allowed drug companies to produce generics of off-patent drugs. There are analytical methods to prove that generics are chemically identical to the original branded drug. The cost to the manufacturer and the consumer is much lower because the approval pathway is much shorter than branded drugs. With the make-up of the drug already approved, generics do not require the added time and cost of research and development. When pharma processors move to proteins like monoclonal antibodies however, certain sugar molecules exist on the outside surface of the protein. There is a lot of variety in how these molecules are positioned and the analytical methodologies that exist today are limited in the degree to which they can confirm absolute identity of all […]

posted by Taj Pharma

11December
2019

Diabetes drug price to halve as patent expires; cheaper versions expected soon

Diabetes drug price to halve as patent expires; cheaper versions expected soon Diabetes drug price: Companies are talking of a significant price cut. Intas Pharmaceuticals, according to a senior official in the company, will hit the market today with two versions Diabetes drug price: There are currently four brands in the Indian market today There is good news for diabetic patients in India. The patent for Vildagliptin, a leading drug to treat diabetes has expired, opening doors for several companies to launch generic versions. Going by the fatigue doctors experience sending away medical representatives who pitch for their version of the drug at prices less than half of what is currently in the market, it is apparent that there are many rushing in. “As Indian pharma companies get ready to launch the branded generic version of Vildagliptin, we might see over 50 new brands launched over the next few days in the Rs 800 core Vildagliptin market in India (in terms of annual sales),” says Hari Natarajan, who has tracked Indian pharma retail sales for years and is the founder and managing director of Pronto Consult, an independent consulting company specialising in doctor perception studies and market Insights in India […]

posted by Taj Pharma

11December
2019

What’s the difference? Biosimilar and generic drugs

Biosimilar drugs are often confused with generic drugs. Both are marketed as cheaper versions of costly name-brand drugs and are designed to have the same clinical effect as their pricier counterparts. But biosimilar drugs and generic drugs are very different. Biosimilar drugs are often confused with generic drugs. Both are marketed as cheaper versions of costly name-brand drugs. Both are available when drug companies’ exclusive patents on expensive new drugs expire. And both are designed to have the same clinical effect as their pricier counterparts. But biosimilar drugs and generic drugs are very different, mainly because while generic drugs are identical to the original in chemical composition, biosimilar drugs are “highly similar,” but close enough in duplication to accomplish the same therapeutic and clinical result. Another key difference is that generics are copies of synthetic drugs, while biosimilars are modeled after drugs that use living organisms as important ingredients. But many experts hope the two will share a critical commonality and that, like generics, biosimilars will dramatically lower the cost of biologic drugs. “ Branded drugs are either synthetic, meaning they’re made from a chemical process, or biological, meaning they’re made from living sources. Synthetic branded drugs can be exactly […]

posted by Taj Pharma

12December
2019

Carcinogens Have Infiltrated the Generic Drug Supply

Carcinogens Have Infiltrated the Generic Drug Supply – {Taj Pharmaceuticals} Valsartan Tablets are free of all Impurities. An FDA quality-control nightmare reveals how impurities end up in blood pressure pills. Valsartan The chemical N-Nitrosodimethylamine, or NDMA, is a yellow liquid that dissolves in water. It doesn’t have an odor or much of a taste. It’s known to cause cancer in animals and is classified as a probable carcinogen in humans—it’s most toxic to the liver. A single dose of less than a milligram can mutate mice cells and stimulate tumors, and 2 grams can kill a person in days. An Oklahoma man poisoned the family of an ex-girlfriend in 1978 by pouring a small vial of NDMA into a pitcher of lemonade. In 2018 a graduate student in Canada sickened a colleague by injecting the chemical into his apple pie. NDMA no longer has industrial uses—it was once added to rocket fuel—but it can form during industrial processes at tanneries and foundries as well as at pesticide, dye, and tire makers. It can be found in drinking water disinfected with chloramine. It’s in tobacco smoke, which is one reason secondhand smoke is dangerous, and it’s what makes eating a lot […]

posted by Taj Pharma

12December
2019

Diabetes: New compounds may lower blood sugar but prevent weight gain

posted by Doctor

15December
2019

Biomarkers could predict which diets are best for weight loss

posted by Doctor

15December
2019

Vegetarian diet more effective for weight loss and metabolism

posted by Doctor

15December
2019

How does high blood sugar (hyperglycemia) feel?

How does high blood sugar (hyperglycemia) feel? Symptoms | Causes Healthy blood sugar | When to see a doctor

posted by Doctor

15December
2019

Cancer treatment cost pushes 6 crore Indians below poverty line every year

Cancer treatment cost pushes 6 crore Indians below poverty line every year Cancer treatment While 16 lakh new cancer cases are diagnosed every year, the annual mortality is eight lakh. The current health infrastructure is grossly inadequate to handle the growing problem of cancer, a parliamentary report says Six crore Indian citizens are pushed below the poverty line every year because of treatment costs associated with cancer in their families, a parliamentary panel report suggests. While 16 lakh new cancer cases are diagnosed every year, the annual mortality is eight lakh. The current health infrastructure is grossly inadequate to handle the growing problem of cancer, the report says. The 325th report of the Parliamentary Standing Committee on Science and Technology, Environment, Forests and Climate Change, which looked into the expanded role of the department of atomic energy in cancer treatment in India through an enlarged network of the Tata Memorial Centre (TMC), pointed out that in the absence of availability of adequate facilities in their own region/states, a majority of cancer patients travel to far-off locations, sometimes thousands of kilometres, for their treatment. “The Committee would like to lay emphasis on the fact that mortality to incidence ratio of 0.68 […]

posted by Taj Pharma

16December
2019

What is Prostate cancer screening test? A large new trial is testing whether MRI scans could be an effective way to screen men for prostate cancer, in a similar way to mammograms offered to women to check for breast cancer. In this article for the BBC, leading expert Prof Mark Emberton explains why finding a suitable screening method for this common male cancer is vital but has proved difficult so far. “Prostate cancer is the most common form of cancer in men, with around 130 new cases diagnosed in the UK every day and more than 10,000 men a year dying from the disease. “Unfortunately, the way we currently spot the disease is not very precise. “Traditionally, we have used a blood test looking for raised levels of prostate-specific antigen (PSA) and then carried out a biopsy which means taking some tissue from the prostate gland to examine under the microscope. “But PSA levels are not a reliable indicator of prostate cancer – about 75% of men who get a positive result are not found to have cancer, while it misses the cancer in about 15% of men with prostate cancer. “So we currently diagnose cancers that are harmless, leading […]

posted by Taj Pharma

24December
2019

FDA Approves First Generic of Popular Blood Thinner

FDA Approves First Generic of Popular Blood Thinner The first generic versions of the powerful blood thinner Eliquis (apixaban) were approved by the U.S. Food and Drug Administration on Monday. Heparin Sodium Injection – Taj Pharmaceuticals “Today’s approvals of the first generics of apixaban are an example of how the FDA’s generic drug program improves access to lower-cost, safe and high-quality medicines,” Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, said in an agency news release. “These approvals mark the first generic approvals of a direct oral anticoagulant,” Woodcock noted. “Direct oral anticoagulants [blood thinners] do not require repeated blood testing.” The two types of generic tablets were approved to reduce the risk of stroke and systemic clotting in the lungs of patients with non-valvular atrial fibrillation and for the prevention of deep vein thrombosis (DVT), which may lead to pulmonary embolism (lung clots), in patients who have had hip or knee replacement surgery. Atrial fibrillation is a heart rhythm disorder that raises the risk of blood clots. It is estimated that between almost 3 and 6 million Americans have atrial fibrillation, according to the U.S. Centers for Disease Control and Prevention. Many of these […]

posted by Taj Pharma

24December
2019

{Taj Pharmaceuticals} Stomach cancer symptoms, diagnosis and treatment

{Taj Pharmaceuticals} Stomach cancer symptoms, diagnosis and treatment: STOMACH cancer is one of the most common types of cancer and one of the top causes of cancer deaths worldwide. Survival rates for the deadly disease stand at just 14 percent. With these worrying statistics its imperative for one to spot the early signs of stomach cancer, and feeling a certain burning sensation could mean you’re at risk. Stomach cancer is characterised by a growth of cancerous cells within the lining of the stomach. Also known as gastric cancer, it’s a type of cancer that is difficult to diagnose. The National Cancer Institute (NCI) estimates there’ll be approximately 28,000 new cases of stomach cancer in 2017. Since stomach cancer usually doesn’t cause any early symptoms, it often goes undiagnosed until after it spreads to other parts of the body. Feeling an acid reflux that persists and a burning sensation could signal the deadly disease. Stomach cancer is directly linked to tumours in the stomach. Risk factors for the disease include a group of blood cancers, a common stomach infection that can sometimes lead to ulcers, tumours in other parts of the digestive system or abnormal growths of tissue that form on […]

posted by Taj Pharma

24December
2019

Going vegan could prevent type 2 diabetes

posted by Doctor

25December
2019

Govt’s generic push will dent Rs 90,000-cr branded pharma market Pharma companies may soon start wooing chemists as the Narendra Modi government plans to make it mandatory for doctors to prescribe pure-generic drugs, instead of branded generics as they do now. Medicines Though the plan was first announced in this year’s Budget, the prime minister spoke about it for the first time at a public event on Monday. The health ministry has now started working on amending the Drugs and Cosmetics Act to this effect. “Indian patients may face quality issues without price benefit as intense competition among marketers will lead to incentivising a chemist,” says D G Shah, secretary-general of the Indian Pharmaceutical Alliance. India, like most of other emerging markets, is predominantly a branded generics play with a 90 per cent share in the Rs 1-lakh-crore market. Which means that drug makers sell these off-patent drugs through their relationships with doctors. In developed countries such as the US, only patented drugs are sold under a brand, which is marketed through their ties to doctors. Off-patent drugs are sold only as pure generic, without using any brand name. It helps in making pure generics cheaper. It is this nexus […]

posted by Taj Pharma

4January
2020

Biosimilars in 2020: All eyes on how Indian pharmas cash in on investments after betting on foreign markets

While over 50 different biosimilars already exist in the Indian market, the big money lies launching these drugs in Europe and the United States It has been more than a decade since Indian pharmaceutical companies began looking at the biosimilar opportunity. It is not an easy space to be in and quite unlike their traditional stronghold of generics. However, it is a space that is linked to the nature of future drugs – today, as is often quoted by pharma experts, one out of every three new drugs approved in the global matkets is a biotech drug, specially in fields like cancer care. While over 50 (and counting) different biosimilars already exist in the Indian market, the big money lies launching these drugs in Europe and the United States. So far, hardly a couple of Indian companies have been able to do this and much of this happened in the decade that has just concluded. In February 2015, Intas Pharmaceuticals became the first Indian company to get a biosimilar registered – the biotech drug Filgratsim under the brand Accofil – in the European Union. It is now getting ready to foray into US with more products. “We launched pegylated granulocyte-colony […]

posted by Taj Pharma

WHO-GMP certified pharma manufacturing facilities manufacturers in India

We are exporting our WHO-GMP certified pharma manufacturing facilities product in Following Countries:- Russia and CIS Countries: Azerbaijan, Armenia, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russia, Tajikistan, Turkmenistan, Uzbekistan and Ukraine GCC/ Middle East Countries: Saudi Arabia, Yemen, Oman, Bahrain, UAE, Lebanon, Jordan, Iraq. African Countries: Nigeria, Tanzania, Sudan, Zambia, Benin, Angola, Liberia Southeast Asia: Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, Vietnam, Brunei Darussalam Other Asian Countries: Nepal, Myanmar, Malaysia, Cambodia, Bhutan, Sri Lanka, Mauritius. WHO-GMP certified pharma manufacturing facilities Regulatory Documents: Certificate of Analysis (COA)Method of Analysis (MOA)Stability Data (Accelerated stability / Long term stability / Zone 4b)CTD Dossier / ACTD Dossiers / eCTD DossiersCertificate of Pharmaceuticals Product (COPP)Free Sale Certificate (FSC) Leading WHO-GMP certified pharma manufacturing facilities Manufacturers, Suppliers in India Taj Pharmaceuticals, one of the leading WHO-GMP certified pharma manufacturing facilities Manufacturers India brings the best-quality products. The company carries the rich experience in the niche manufacturing of WHO-GMP certified pharma manufacturing facilities. Taj Pharmaceuticals is reputed manufacturer and WHO-GMP certified pharma manufacturing facilities suppliers in India prefer Taj Pharmaceuticals due to the reliability and purity of products. Taj Pharmaceuticals, the well-known WHO-GMP certified pharma manufacturing facilities API Manufacturer in India gives the assurance of high-quality […]

posted by Taj Pharma

7January
2020

posted by Taj Pharma

13January
2020

Kids born with assisted reproduction are not at higher risk of getting cancer

Kids born with assisted reproduction are not at higher risk of getting cancer Recently, Allison and Honjo have been awarded with the Nobel prize for their findings leading to the new cancer treatment approaches known as immune checkpoint inhibitors (ICIs). Thanks to these discoveries in fact, the management of the disease has profoundly changed, producing remarkable results on several tumors, even if checkpoint inhibitors have significant side effects, that according to an analysis published in Jama are still poorly known by many health professionals. It is “urgent”, according to authors, “to identify who is at highest risk of severe outcomes, and then develop evidence-based therapies to manage toxicity”. Understanding these adverse effects is essential not for oncologist only, but for every physician in any discipline, as said by Douglas B. Johnson, MD, of Vanderbilt University, Nashville, Tennessee, and colleagues. Indeed, they underlined what are the most common effects which occur in practice in an article published online in JAMA. Many organs can be involved, commonly the skin, the gastrointestinal tract, the lungs, endocrine organs, musculoskeletal, renal, nervous, hematologic, cardiovascular, and ocular systems, thus counting such side effects as a problem to be faced jointly among the various physicians. Autoimmune events are […]

posted by Taj Pharma

15January
2020

posted by Taj Pharma

16January
2020

What happens if chemotherapy does not work?

Radiation therapy | Immunotherapy | Hormone therapy | Targeted therapy | Making a decision | Outlook | Takeaway Doctors use chemotherapy either as a first-line therapy or in combination with other treatments, such as surgery. If chemotherapy does not work, a person may need to consider other treatment options.

posted by Taj Pharma

22January
2020

{Taj Pharma} Why do some cancers metastasise, but others don’t?

posted by Taj Pharma

23January
2020

Magnetised molecules used to monitor breast cancer

Magnetised molecules used to monitor breast cancer {Taj Pharmaceuticals} [Mumbai Chronicle]

posted by Taj Pharma

23January
2020

posted by Taj Pharma

10February
2020

posted by Taj Pharma

27February
2020

The making of a living ovarian cancer biobank

posted by Taj Pharma

29February
2020

{Taj Pharma Cancer Awareness Initiative} Genetic ‘fingerprints’ implicate gut bacterium in bowel cancer

posted by Taj Pharma

2March
2020

This is how HIV decides to become active

This is how HIV decides to become active Researchers have found the molecular mechanism underpinning HIV’s decision to remain in an active or dormant state. This may lead to new therapies that work by keeping the virus in a permanently dormant state. The study, led by a team from the Gladstone Institutes in San Francisco, CA, features in a paper now published in the journal Cell. The findings may also explain cell fate decisions that occur elsewhere in biology — such as how stem cells decide whether to remain as stem cells or differentiate into specialized cells, including brain or heart cells, when they divide. Senior study author Prof. Leor S. Weinberger, the director of the Center for Cell Circuitry at the Gladstone Institutes, likens the process to how we “hedge our bets” when we make decisions about financial investments. To “protect against volatility in the market,” we may choose to place some funds in high-risk stocks with potentially high yields and the rest in low-risk, low-yield options. “Similarly,” he explains, “HIV covers its bases in a volatile environment by generating both active and dormant infections.” HIV latent reservoir: Once it enters the human body, HIV inserts its genetic material […]

posted by Taj Pharma

11March
2020

posted by Taj Pharma

18March
2020

{Taj Pharma India} How the coronavirus (COVID-19) test works

posted by Taj Pharma

19March
2020

Taj Pharmaceuticals: Our commitment to clients in the spread of COVID-19

We Taj Pharmaceuticals are in the midst of challenging times, brought upon us due to the unimaginable spread of COVID-19. As we grapple with this difficult and ever evolving situation, we wanted to reach out to make sure that you are doing okay and in case you needed any help. It is hard to think of a business that is not impacted by this pandemic, the effects of which we will all continue to feel for a long time. Considering the current situation across the globe wherein everyone is trying their best to tackle the Coronavirus pandemic, we understand that we aren’t insulated from any uncertainties too. We, as an organisation, are doing our bit to ensure the safety and security of our employees, partners, etc. while ensuring that the work isn’t hampered. coronavirus As a firm, we have always placed the highest emphasis on delivering quality generics to all our clients, consistently. I want to take this opportunity to assure you that our professional commitments continue to occupy an important place for all of us at Taj Pharmaceuticals even as we steer our way through the crisis. Our Values of Care and Working Together come to fore in difficult […]

posted by Doctor

Contract Manufacturing

Pharmaceutical Contract Manufacturing

Third Party Pharma Manufacturing

Third Party Pharma Manufacturing Company

Pharmaceutical Exports

GMP certified pharmaceutical company fully geared for exports

Formulation Development

We are technology driven company supported by extensive F&D department; coupled with well-equipped laboratories and best talented technical officials of the industry

Regulatory Affairs & Documentations

We have a highly skilled team of regulatory affairs specialists who are well versed with regulatory policies and procedures around the world.

Quality Control

We have a well-equipped Quality Control (QC) laboratory, which ensures that our products are pure, safe and effective and are released only after thorough analysis as per stringent procedures.

Contract Manufacturing

Pharmaceutical Contract Manufacturing

Third Party Pharma Manufacturing

Third Party Pharma Manufacturing Company

Pharmaceutical Exports

GMP certified pharmaceutical company fully geared for exports

Formulation Development

We are technology driven company supported by extensive F&D department; coupled with well-equipped laboratories and best talented technical officials of the industry

Regulatory Affairs & Documentations

We have a highly skilled team of regulatory affairs specialists who are well versed with regulatory policies and procedures around the world.

Quality Control

We have a well-equipped Quality Control (QC) laboratory, which ensures that our products are pure, safe and effective and are released only after thorough analysis as per stringent procedures.

Visit our Vast Generic Medicines Portfolio

Domestic Only

Latest News on Your Doctor's Blog

Contract Manufacturing

Third Party Pharma Manufacturing

Pharmaceutical Exports

Formulation Development

Regulatory Affairs & Documentations

Quality Control

Contract Manufacturing

Third Party Pharma Manufacturing

Pharmaceutical Exports

Formulation Development

Regulatory Affairs & Documentations

Quality Control